Pfizer Trials Farce Exposed in Medical Journal

Pfizer Trials Farce Exposed in Medical Journal

The clinical tests carried out by Pfizer before the release of its hugely profitable Covid-19 vaccine were deeply flawed. The truth is now out, although the shocking truth is still being kept from the public by a cover-up by the mass media and political elites around the world.

This is not some ‘tinfoil hat conspiracy theory - the dreadful truth about the Pfizer vaccine emerged on November 2nd in the authoritative British Medical Journal. The headline sets the tone for the whole of the article: Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial.

The devastating piece continues with the sub-heading: “Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight.”

A regional director who was employed on the trials at the research organisation Ventavia Research Group told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding.

Eemployed at Ventavia in September 2020, Brook Jackson repeatedly informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues

After repeatedly notifying Ventavia of these problems, Jackson - the regional director of the Texas-based trials operation - emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her that very same day.

Jackson told The BMJ it was the first time she had been fired in her 20 year career in research.

Two former Ventavia employees spoke to The BMJ anonymously for fear of reprisal and loss of job prospects. Both confirmed broad aspects of Jackson’s complaint. One said that she had worked on over four dozen clinical trials in her career, including many large trials, but had never experienced such a “helter skelter” work environment as with Ventavia on Pfizer’s trial.

“I’ve never had to do what they were asking me to do, ever,” she told The BMJ. “It just seemed like something a little different from normal—the things that were allowed and expected.”

Since Jackson reported problems with Ventavia to the FDA in September 2020, Pfizer has hired Ventavia as a research subcontractor on four other Covid vaccine clinical trials: in children and young adults; pregnant women, and a booster dose, as well an RSV vaccine trial. Obviously it’s getting the profitably correct answers, not the medical truth, that matters to Pfizer.

The full BMJ article may be found here: